Prevalence and Risk Factors of Subclinical Hypothyroidism in Young and Middle-Aged Patients With First-Episode Drug-Naïve Major Depressive Disorder

IF 3.3 2区 医学 Q1 PSYCHIATRY Depression and Anxiety Pub Date : 2025-04-17 DOI:10.1155/da/3154096
Jiacheng Liu, Liying Yang, Chuanyi Kang, Xiaohong Wang, Na Zhao, Xiangyang Zhang
{"title":"Prevalence and Risk Factors of Subclinical Hypothyroidism in Young and Middle-Aged Patients With First-Episode Drug-Naïve Major Depressive Disorder","authors":"Jiacheng Liu,&nbsp;Liying Yang,&nbsp;Chuanyi Kang,&nbsp;Xiaohong Wang,&nbsp;Na Zhao,&nbsp;Xiangyang Zhang","doi":"10.1155/da/3154096","DOIUrl":null,"url":null,"abstract":"<div>\n <p><b>Background:</b> Subclinical hypothyroidism (SCH) is a mild impairment of thyroid function. The prevalence of SCH is significantly higher in the major depressive disorder (MDD) population than in the general population, but the risk factors and relationships are not apparent. The occurrence of SCH is influenced by age and medication. Therefore, our study was to investigate the prevalence and risk factors of SCH in young and middle-aged groupstotal of patients with first-episode and drug-naive (FEDN) MDD.</p>\n <p><b>Methods:</b> A total of 1717 FEDN MDD patients were divided into a younger group (18–45 years) and a middle-aged group (&gt;45 years). The Hamilton Depression Scale (HAMD) was used to assess patients’ depression symptoms. Serum thyroid function and lipid level parameters were measured. A self-administered questionnaire collected other clinical and demographic data.</p>\n <p><b>Results:</b> The prevalence of SCH in middle-aged MDD patients was 66.9%. Middle-aged patients had a longer duration of illness, a later age of onset, a higher proportion of female patients, and a lower level of education. Further logistic regression indicated that serum total cholestrol (TC) and high-density lipoprotein cholesterol (HDL-C) levels, as well as overweight and obesity, were significantly associated with SCH in both groups; however, low-density lipoprotein cholesterol (LDL-C) was an independent risk factor associated with SCH in the middle-aged group.</p>\n <p><b>Conclusions:</b> Our results suggest that the prevalence of SCH is higher in middle-aged MDD patients than in younger patients and that long-term more severe depression, high TC and HDL-C levels, and abnormal body weight may influence the occurrence of SCH. Physicians should pay more attention to LDL-C levels in middle-aged patients with FEDN MDD.</p>\n </div>","PeriodicalId":55179,"journal":{"name":"Depression and Anxiety","volume":"2025 1","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/da/3154096","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Depression and Anxiety","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/da/3154096","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Subclinical hypothyroidism (SCH) is a mild impairment of thyroid function. The prevalence of SCH is significantly higher in the major depressive disorder (MDD) population than in the general population, but the risk factors and relationships are not apparent. The occurrence of SCH is influenced by age and medication. Therefore, our study was to investigate the prevalence and risk factors of SCH in young and middle-aged groupstotal of patients with first-episode and drug-naive (FEDN) MDD.

Methods: A total of 1717 FEDN MDD patients were divided into a younger group (18–45 years) and a middle-aged group (>45 years). The Hamilton Depression Scale (HAMD) was used to assess patients’ depression symptoms. Serum thyroid function and lipid level parameters were measured. A self-administered questionnaire collected other clinical and demographic data.

Results: The prevalence of SCH in middle-aged MDD patients was 66.9%. Middle-aged patients had a longer duration of illness, a later age of onset, a higher proportion of female patients, and a lower level of education. Further logistic regression indicated that serum total cholestrol (TC) and high-density lipoprotein cholesterol (HDL-C) levels, as well as overweight and obesity, were significantly associated with SCH in both groups; however, low-density lipoprotein cholesterol (LDL-C) was an independent risk factor associated with SCH in the middle-aged group.

Conclusions: Our results suggest that the prevalence of SCH is higher in middle-aged MDD patients than in younger patients and that long-term more severe depression, high TC and HDL-C levels, and abnormal body weight may influence the occurrence of SCH. Physicians should pay more attention to LDL-C levels in middle-aged patients with FEDN MDD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中青年首发忧郁症患者亚临床甲状腺功能减退症的患病率及危险因素Drug-Naïve
背景:亚临床甲状腺功能减退症(SCH)是一种轻微的甲状腺功能障碍。重度抑郁障碍(MDD)人群的SCH患病率明显高于普通人群,但危险因素和关系不明显。SCH的发生受年龄和用药的影响。因此,我们的研究是探讨SCH在首发和药物naive (FEDN) MDD患者中青年群体中的患病率和危险因素。方法:将1717例FEDN MDD患者分为青壮年组(18-45岁)和中年组(45岁)。采用汉密尔顿抑郁量表(HAMD)评估患者的抑郁症状。测定血清甲状腺功能及血脂水平参数。一份自我管理的问卷收集了其他临床和人口统计数据。结果:中年MDD患者中SCH患病率为66.9%。中年患者病程较长,发病年龄较晚,女性患者比例较高,文化程度较低。进一步的logistic回归表明,两组患者血清总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)水平以及超重和肥胖与SCH显著相关;然而,低密度脂蛋白胆固醇(LDL-C)是与中年组SCH相关的独立危险因素。结论:我们的研究结果提示,中年MDD患者SCH的患病率高于年轻患者,长期更严重的抑郁、高TC和高HDL-C水平以及体重异常可能影响SCH的发生,医生应重视中年FEDN MDD患者LDL-C水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Depression and Anxiety
Depression and Anxiety 医学-精神病学
CiteScore
15.00
自引率
1.40%
发文量
81
审稿时长
4-8 weeks
期刊介绍: Depression and Anxiety is a scientific journal that focuses on the study of mood and anxiety disorders, as well as related phenomena in humans. The journal is dedicated to publishing high-quality research and review articles that contribute to the understanding and treatment of these conditions. The journal places a particular emphasis on articles that contribute to the clinical evaluation and care of individuals affected by mood and anxiety disorders. It prioritizes the publication of treatment-related research and review papers, as well as those that present novel findings that can directly impact clinical practice. The journal's goal is to advance the field by disseminating knowledge that can lead to better diagnosis, treatment, and management of these disorders, ultimately improving the quality of life for those who suffer from them.
期刊最新文献
Anxiety and Depressive Symptoms Before and During the COVID-19 Pandemic: A Longitudinal Network Analysis. Associations Among Depression, Self-Compassion, and Learning Burnout in Nursing Students: A Three-Wave Longitudinal Study. Anxiety Suppressed Prefrontal Cortex Brain Activity: Insights From a Large Sample of Functional Near-Infrared Spectroscopy (fNIRS) Data. Changes in Hospitalization for Eating Disorders and Related Suicidal Risk, Following COVID-19 Pandemic. The Sleep Symptoms Are Directly Associated With Suicide Risk in Adolescents and Youth Patients With Depression.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1